CD8A and neoplasm: The number of CD8+ T cells present in the tumoral regions (Figure 3A) was counted by the QuPath software and plotted in Figure 3B. While the number of tumour-infiltrated CD8+ T cells was very low in control tumours, it dramatically increased in N6L-treated mice (Figure 3A arrows, and Figure 3B).